Characterization of the Antidiabetic Role of Parkinsonia aculeata (Caesalpineaceae)‎

Abstract EN

This paper reports the characterization of the antidiabetic role of a hydroethanolic extract from Parkinsonia aerial parts (HEPA), in normal and alloxan-induced diabetic rats, treated with HEPA (125 and 250 mg/kg; p.o.).

Oral glucose tolerance test, acute oral toxicity test and preliminary phytochemical analyses were performed.

The diabetic rats treated with HEPA showed a significant reduction in serum and urinary glucose, urinary urea and triglyceride levels, as compared to the diabetic untreated group.

However, in the normal treated groups, a significant reduction was found only in serum triglyceride levels.

In all treated diabetic groups, an improvement in hepatic glycogen was observed, as well as a decrease in liquid intake and urinary volume, and an enhancement in the weight of skeletal muscles (soleus and extensor digitorum longus), kidneys and epididymal adipose tissue.

Nevertheless, body and liver weights were ameliorated only in the diabetic group treated with HEPA (250 mg/kg).

Moreover, oral glucose tolerance was higher in animals treated with HEPA, while results also showed that HEPA could be considered toxicologically safe.

Phytochemical analysis revealed the presence of tanins, flavonoids and steroids in HEPA.

In conclusion, P.

aculeata presents an antidiabetic activity and other beneficial effects that ameliorate diabetes and associated complications.